venous thrombosis - caval filter - all type of patients clinical trials results meta-analysis

<h1> <a href="TM21-64-cavalfilter-venousthrombosis.html"> <strong>venous thrombosis</strong> - caval filter </a> - all type of patients trial results systematic overview and meta-analysis </h1> <h2>Main characteristics of the included studies</h2> <table> <tr> <th>Trial</th> <th>Treatments</th> <th>Patients</th> <th>Methods</th> </tr> <tr> <td> <a href="index.html"> PREPIC, 1998 </a> <br> </td> <td> caval filter<br>  <i>versus</i> <br> no filter </td> <td> patients with documented proximal DVT or PE, and considered high risk for pulmonary embolism </td> <td> follow-up 12 days and 2 years<br> n=200/200<br> Parallel groups<br> open <br> </td> </tr> </table> <h2>References</h2> <p> <b>PREPIC, 1998 : </b> Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau GA clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Pr�vention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. <i>N Engl J Med 1998;338:409-15</i> [PMID 9459643] </p> <p> <b>PREPIC, 1998 : </b> Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. <i>Circulation 2005;112:416-22</i> [PMID 16009794] </p>